Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Dermatologic 2Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Advanced Solid Tumors 23Advanced Solid Tumor 16Mesothelioma 15Solid Tumors 13Mesothelioma, Malignant 11Ovarian Neoplasms 8Hematopoietic and Lymphatic System Neoplasm 7Solid Tumor 6Pancreatic Neoplasms 6Colorectal Neoplasms 6Stomach Neoplasms 5Neoplasms 5Malignant Solid Neoplasm 5Sarcoma 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Solid Tumours 3Solid Tumor, Adult 3Retinoblastoma 3Kidney Neoplasms 3Advanced Solid Tumour 3Advanced Malignant Solid Tumors 3Thymoma 2Small Cell Lung Carcinoma 2Locally Advanced or Metastatic Solid Tumors 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Squamous Cell × Other solid neoplasm × 30 days × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡